- Home
- SNTG vs POAI Comparison
SNTG vs POAI Comparison
Compare SNTG & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTG
- POAI
- Stock Information
- Founded
- SNTG 2009
- POAI 2002
- Country
- SNTG China
- POAI United States
- Employees
- SNTG N/A
- POAI N/A
- Industry
- SNTG Finance: Consumer Services
- POAI Industrial Specialties
- Sector
- SNTG Finance
- POAI Health Care
- Exchange
- SNTG Nasdaq
- POAI Nasdaq
- Market Cap
- SNTG 4.8M
- POAI 8.9M
- IPO Year
- SNTG 2021
- POAI N/A
- Fundamental
- Price
- SNTG $1.82
- POAI $0.84
- Analyst Decision
- SNTG
- POAI Hold
- Analyst Count
- SNTG 0
- POAI 1
- Target Price
- SNTG N/A
- POAI N/A
- AVG Volume (30 Days)
- SNTG 6.5K
- POAI 101.5K
- Earning Date
- SNTG 07-07-2025
- POAI 08-12-2025
- Dividend Yield
- SNTG N/A
- POAI N/A
- EPS Growth
- SNTG N/A
- POAI N/A
- EPS
- SNTG N/A
- POAI N/A
- Revenue
- SNTG $107,507.00
- POAI $1,729,269.00
- Revenue This Year
- SNTG N/A
- POAI $486.27
- Revenue Next Year
- SNTG N/A
- POAI $65.50
- P/E Ratio
- SNTG N/A
- POAI N/A
- Revenue Growth
- SNTG N/A
- POAI 24.17
- 52 Week Low
- SNTG $1.43
- POAI $0.55
- 52 Week High
- SNTG $3.97
- POAI $3.06
- Technical
- Relative Strength Index (RSI)
- SNTG 54.53
- POAI 38.00
- Support Level
- SNTG $1.67
- POAI $0.85
- Resistance Level
- SNTG $1.92
- POAI $0.91
- Average True Range (ATR)
- SNTG 0.09
- POAI 0.06
- MACD
- SNTG 0.01
- POAI -0.00
- Stochastic Oscillator
- SNTG 62.96
- POAI 4.12
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.